Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI

多发性硬化症的病变活动性和萎缩:多中心 MRI 分析

基本信息

项目摘要

DESCRIPTION (provided by applicant): The relation between inflammatory lesions and atrophy (global, tissue-specific, and regional) that is thought to represent neurodegeneration in multiple sclerosis (MS) is of fundamental importance in understanding the pathogenesis of this disease. We hypothesize that the activity and spatial location of the lesions drive the subsequent atrophy in MS. This hypothesis will be verified by analyzing the MRI data acquired on the CombiRx cohort. CombiRx is a multi-center, double blinded clinical trial with 1008 enrolled patients. Patients are being followed over a minimum period of 3 years with all patients followed until the last patient completes in January 2012 allowing for up to 6.5 years of follow up on some patients. MRI data on this cohort is acquired with a rigorous MRI protocol and the treatment assignments have remained constant. The five specific aims of this proposal are: 1) automatic identification of T2-hyperintense, T1- hypointense, and Gd enhancing lesions and their spatial location, 2) determine the cortical thinning that is a measure of cortical pathology,3) assess the pathology in the normal appearing brain tissue based on the T2 values, determined on a voxel-by voxel basis using the dual echo images, 4) determine the whole brain, tissue specific, and regional atrophy, and 5) determine the effect of lesion activity and their spatial location on the regional atrophy and examine the role of MRI measures as possible biomarkers/predictors of the disease. The image segmentation will be performed using the multi- spectral segmentation in combination with the atlas-based techniques. Activity of both T2-hyperintense and T1- hypointense lesions will be determined by subtracting images acquired at different time points following diffeomorphic nonlinear image registration. Regional atrophy will be determined using the tensor based morphometry. The effect of connectivity between the lesion location and regional atrophy will be investigated using the white matter atlas. Finally composite MRI measures will be correlated with both EDSS (extended disability status scale) and MSFC (MS functional scale) and their individual components. This strategy that includes spatial information should allow identification of robust biomarkers/predictors of the disease. The analysis based on a large and clinically well characterized cohort followed over a relatively long period of time to understand the relationship between inflammation and neurodegeneration is a unique feature of this proposal. Abbreviations: CNS (central nervous system); DGM (deep gray matter structures); DIR (double inversion recovery); DSI (Dice similarity index); DTI (diffusion tensor imaging); EDSS (extended disability status scale); FoE (field of expert); GM (gray matter); ICBM (international consortium for brain mapping); MNI (Montreal Neurologic Institute); MRF (Markov random field); MRI (magnetic resonance imaging); MRIAP (MRI Automated Processing); MRS (magnetic resonance spectroscopy); MS (multiple sclerosis); MSFC (MS functional composite); MTR (magnetization transfer ratio); NABT (normal appearing brain tissue); NAWM (normal appearing white matter); PD (proton density); RGM (regional GM); RRMS (relapsing remitting MS); RWM (regional white matter); SIENAX (Structural Image Evaluation, including Normalization, of Atrophy (X-sectional); SPM (statistical parametric mapping); TBM (tensor based morphometry); TOADS (Topology preserving Anatomical Segmentation); VBM (voxel based morphometry); WM (white matter)
描述(由申请人提供):炎性病变和萎缩(全身性、组织特异性和区域性)之间的关系被认为代表多发性硬化症(MS)的神经退行性变,这对于理解这种疾病的发病机制至关重要。我们假设病变的活动和空间位置驱动ms随后的萎缩,这一假设将通过分析CombiRx队列获得的MRI数据来验证。CombiRx是一项多中心、双盲临床试验,共有1008名入组患者。患者的随访时间至少为3年,所有患者随访至2012年1月最后一位患者完成,随访时间长达6.5年

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PONNADA A NARAYANA其他文献

PONNADA A NARAYANA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PONNADA A NARAYANA', 18)}}的其他基金

Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI
多发性硬化症的病变活动性和萎缩:多中心 MRI 分析
  • 批准号:
    8433698
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI
多发性硬化症的病变活动性和萎缩:多中心 MRI 分析
  • 批准号:
    8662822
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI
多发性硬化症的病变活动性和萎缩:多中心 MRI 分析
  • 批准号:
    9084664
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI
多发性硬化症的病变活动性和萎缩:多中心 MRI 分析
  • 批准号:
    8851691
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Translational MR Imaging in Cocaine Pharmacotherapy Development
可卡因药物疗法开发中的转化磁共振成像
  • 批准号:
    8004216
  • 财政年份:
    2010
  • 资助金额:
    $ 32.09万
  • 项目类别:
Integrated Automated Software Tools for Fast Analysis of Magnetic Resonance Spect
用于快速分析磁共振波谱的集成自动化软件工具
  • 批准号:
    7500550
  • 财政年份:
    2009
  • 资助金额:
    $ 32.09万
  • 项目类别:
MRI of Angiogenesis in Spinal Cord Injury
脊髓损伤血管生成的 MRI
  • 批准号:
    6965519
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
MRI of Angiogenesis in Spinal Cord Injury
脊髓损伤血管生成的 MRI
  • 批准号:
    7105461
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
MRI of Angiogenesis in Spinal Cord Injury
脊髓损伤血管生成的 MRI
  • 批准号:
    7628075
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
MRI of Angiogenesis in Spinal Cord Injury
脊髓损伤血管生成的 MRI
  • 批准号:
    7475705
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 32.09万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 32.09万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 32.09万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 32.09万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 32.09万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了